Cumberland Pharmaceutical Inc (CPIX)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 92.93M | 89.47M | 89.38M | 87.75M | 81.78M | 81.51M | 78.52M | 76.75M |
流動資産合計 | 45.87M | 43.81M | 43.68M | 41.77M | 35.71M | 36.21M | 35.58M | 35.24M |
現金および同等物 | 19.76M | 16.39M | 18.25M | 18.51M | 18.32M | 18.55M | 17.34M | 17.47M |
非流動資産合計 | 47.34M | 45.66M | 45.7M | 45.98M | 46.43M | 45.67M | 42.94M | 41.51M |
負債合計 | 56.95M | 53.42M | 52.54M | 52.1M | 52.52M | 54.32M | 52.49M | 52.28M |
流動負債合計 | 28.58M | 25.71M | 26.96M | 27.33M | 27.98M | 26.43M | 24.76M | 31.09M |
非流動負債合計 | 44.57M | 43.78M | 38.73M | 37.69M | 37.32M | 43.98M | 43.82M | 31.29M |
普通株 | 47.48M | 47.38M | 47.3M | 47.19M | 47.09M | 46.92M | 46.87M | 46.84M |
留保所得 | -11.21M | -11.02M | -10.14M | -11.19M | -17.49M | -19.43M | -20.52M | -22.06M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 93.41M | 93.23M | 112.69M | 104.55M | 96.46M | 84.46M | 92.93M | 81.78M |
流動資産合計 | 65.55M | 68.69M | 59.12M | 50.16M | 49.97M | 45.69M | 45.87M | 35.71M |
現金および同等物 | 34.51M | 45.41M | 27.94M | 28.21M | 24.75M | 27.04M | 19.76M | 18.32M |
非流動資産合計 | 73.12M | 63.92M | 55.57M | 51.09M | 46.87M | 42.6M | 35.97M | 29.26M |
負債合計 | 20.28M | 29.31M | 57.12M | 53.46M | 49.59M | 41.86M | 56.95M | 52.52M |
流動負債合計 | 14.79M | 17.69M | 27.8M | 24.15M | 25.67M | 19.28M | 28.58M | 27.98M |
非流動負債合計 | 9.59M | 21.42M | 49.32M | 47.81M | 38.92M | 37.58M | 44.57M | 37.32M |
総資本 | 73.12M | 63.92M | 55.57M | 51.09M | 46.87M | 42.6M | 35.97M | 29.26M |
普通株 | 54.64M | 52.41M | 51.1M | 49.91M | 49.12M | 48.45M | 47.48M | 47.09M |
留保所得 | 18.61M | 11.71M | 4.75M | 1.21M | -2.13M | -5.64M | -11.21M | -17.49M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約